- Home
- LTC vs ARDX Comparison
LTC vs ARDX Comparison
Compare LTC & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTC
- ARDX
- Stock Information
- Founded
- LTC 1992
- ARDX 2007
- Country
- LTC United States
- ARDX United States
- Employees
- LTC N/A
- ARDX N/A
- Industry
- LTC Real Estate Investment Trusts
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- LTC Real Estate
- ARDX Health Care
- Exchange
- LTC Nasdaq
- ARDX Nasdaq
- Market Cap
- LTC 1.5B
- ARDX 1.3B
- IPO Year
- LTC 1992
- ARDX 2014
- Fundamental
- Price
- LTC $35.75
- ARDX $4.82
- Analyst Decision
- LTC Buy
- ARDX Strong Buy
- Analyst Count
- LTC 4
- ARDX 8
- Target Price
- LTC $38.25
- ARDX $10.19
- AVG Volume (30 Days)
- LTC 346.6K
- ARDX 5.8M
- Earning Date
- LTC 05-05-2025
- ARDX 05-01-2025
- Dividend Yield
- LTC 6.38%
- ARDX N/A
- EPS Growth
- LTC N/A
- ARDX N/A
- EPS
- LTC 2.04
- ARDX N/A
- Revenue
- LTC $201,599,000.00
- ARDX $333,615,000.00
- Revenue This Year
- LTC N/A
- ARDX $15.76
- Revenue Next Year
- LTC $3.53
- ARDX $34.54
- P/E Ratio
- LTC $17.52
- ARDX N/A
- Revenue Growth
- LTC 5.10
- ARDX 168.06
- 52 Week Low
- LTC $31.24
- ARDX $4.02
- 52 Week High
- LTC $39.89
- ARDX $9.33
- Technical
- Relative Strength Index (RSI)
- LTC 58.86
- ARDX 49.22
- Support Level
- LTC $33.20
- ARDX $4.51
- Resistance Level
- LTC $34.45
- ARDX $4.70
- Average True Range (ATR)
- LTC 1.10
- ARDX 0.31
- MACD
- LTC 0.12
- ARDX 0.03
- Stochastic Oscillator
- LTC 91.84
- ARDX 81.12
About LTC LTC Properties Inc.
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.